Episode 1: TNF-Alpha: Concept to Proof of Concept episode artwork

EPISODE · May 30, 2008 · 14 MIN

Episode 1: TNF-Alpha: Concept to Proof of Concept

from Biologic Therapy In Rheumatoid Arthritis · host Rheumatology News International

Professor Sir Ravinder Maini's groundbreaking work on the characterization of TNF-alpha began in the mid-1980's with his collaboration with Professor Mark Feldman. In his study of intercellular messenger molecules, Professor Sir Maini utilized two new technologies -- protein sequencing and cDNA protein coding -- to investigate half a dozen cytokines that appeared to mediate the pathogenesis of connective tissue diseases. One of them, TNF-alpha, proved to play a pivotal role in the cascading interaction of cytokines. When antibody against TNF-alpha was produced, a new field of biologic therapy in the management of rheumatic diseases was born. In this interview, Professor Sir Maini describes the scientific discovery that earned him the title "Father of Translational Research." Listen to him describe this historic exploration in his own words. The podcast also features: Inflammation is Hallmark of Coronary Disease in RA

Episode metadata supplied by the publisher feed · Published May 30, 2008

Embed this episode

NOW PLAYING

Episode 1: TNF-Alpha: Concept to Proof of Concept

0:00 14:53

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Biologic Therapy In Rheumatoid Arthritis?

This episode is 14 minutes long.

When was this Biologic Therapy In Rheumatoid Arthritis episode published?

This episode was published on May 30, 2008.

Can I download this Biologic Therapy In Rheumatoid Arthritis episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!